SALE EXTENDED
MarketBeat All Access
Start your 30-day free trial,
then continue your subscription for 50% off.
TODAY ONLY!
Claim Your Discount
×
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
Free Webinar | October 11: How to Break Barriers
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
3 Stocks With Market-Beating Price Performance
Don’t Chase American Virtual Cloud Technologies Higher
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
Free Webinar | October 11: How to Break Barriers
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
3 Stocks With Market-Beating Price Performance
Don’t Chase American Virtual Cloud Technologies Higher
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
Free Webinar | October 11: How to Break Barriers
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
3 Stocks With Market-Beating Price Performance
Don’t Chase American Virtual Cloud Technologies Higher
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
S&P 500   3,744.52
DOW   29,926.94
QQQ   279.76
Free Webinar | October 11: How to Break Barriers
Live Updates: Russia-Ukraine War
Box Inc. Stock on Track to Become a Q4 Winner
3 Stocks With Market-Beating Price Performance
Don’t Chase American Virtual Cloud Technologies Higher
Is Ford's Revenue Enough to Juice its Stock Price?
Will WWE Shares Wrestle Their Way Higher or Will They Tap Out?
NASDAQ:ATXI

Avenue Therapeutics - ATXI Earnings Date, Estimates & Call Transcripts

$6.29
-2.18 (-25.74%)
(As of 10/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$6.14
$8.42
50-Day Range
$3.21
$67.50
52-Week Range
$3.00
$27.75
Volume
2.64 million shs
Average Volume
7.17 million shs
Market Capitalization
$9.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Earnings Summary

Skip Charts & View Estimated and Actual Earnings Data

ATXI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ATXI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ATXI Earnings Date and Information

Avenue Therapeutics last issued its earnings data on August 15th, 2022. The reported ($0.45) earnings per share (EPS) for the quarter. Avenue Therapeutics has generated ($4.05) earnings per share over the last year (($4.05) diluted earnings per share). Avenue Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 21st, 2022 based off prior year's report dates.

Avenue Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/21/2022
(Estimated)
        
8/15/2022Q2 2022($0.45)($0.45)($0.03)
5/16/2022Q1 2022($2.10)($2.10)($0.14)
11/14/2021Q3($0.75)($0.75)
8/15/2021Q2($0.90)($0.90)    
5/16/2021Q1($0.90)($0.90)
3/30/2021Q4($0.90)($0.90)
11/4/2020Q3 2020($1.50)($0.90)+$0.60($0.06)  
8/14/20206/30/2020($1.65)($1.65)($0.11)
5/11/20203/31/2020($2.55)($1.20)+$1.35($0.08)
3/30/2020Q4 2019($4.2750)($4.9368)($0.6618)($0.32)
11/4/2019Q3 2019($4.80)($2.10)+$2.70($0.14)
8/14/2019Q2 2019($7.20)($6.45)+$0.75($0.43)
5/13/20193/31/2019($6.45)($12.30)($5.85)($0.82)
3/12/2019Q4 2018($7.05)($5.70)+$1.35($0.38)
11/14/2018Q3 2018($5.25)($3.75)+$1.50($0.25)
8/14/2018Q2 2018($10.1550)($6.75)+$3.4050($0.45)
5/3/2018Q1 2018($10.35)($15.45)($5.10)($1.03)
3/1/2018Q4 2017($9.45)($9.45)($0.63)
11/9/2017Q3 2017($3.75)($4.50)($0.75)($0.30)
8/11/2017Q2 2017($8.10)($8.10)($0.38)












Avenue Therapeutics Earnings - Frequently Asked Questions

When is Avenue Therapeutics's earnings date?

Avenue Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 21st, 2022 based off last year's report dates. Learn more on ATXI's earnings history.

How much profit does Avenue Therapeutics generate each year?

Avenue Therapeutics (NASDAQ:ATXI) has a recorded net income of -$3.73 million. ATXI has generated -$4.05 earnings per share over the last four quarters.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:ATXI) was last updated on 10/7/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.